New approach to reduce allograft tissue immunogenicity. Experimental data.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Immunology

Background:

• Allograft degeneration is often caused by immune rejection.
• Existing decellularization methods limit allograft use to the pulmonic position.
• A novel devitalization protocol using digitonin and ethylenediaminetetraacetic acid was developed to induce cell death and suppress calcification.

Purpose of the Study:

• To evaluate the efficacy of a new anticalcinosis devitalization technology for heart valve allografts.
• To assess the biocompatibility and immune response of devitalized allografts in a chronic canine model.

Main Methods:

• Two groups of canine aortic allografts were implanted: cryopreserved viable (Group 1) and devitalized (Group 2).
• Allografts were explanted after four months for histological and fluorescence microscopy analysis.
• Absorption spectroscopy was used to detect mineralized calcium, and tissue matrix integrity was assessed.

Main Results:

• Devitalization successfully eliminated viable cells and prevented calcification without damaging the tissue matrix.
• No significant repopulation by recipient cells was observed in either group over four months.
• Devitalized allografts showed reduced immune cell infiltration and absence of dissection compared to viable allografts.

Conclusions:

• The novel devitalization technology effectively reduces immune response to homologous tissues.
• This method preserves the elasto-mechanic properties and collagenous structure of allografts.
• Anticalcinosis devitalization shows promise for enhancing allograft biocompatibility.